Citadel Advisors
MBII

Citadel Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Citadel Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,791
Closed -$32K – 14794
2022
Q1 		$32K Sell
29,791
-85,222
-74% -$64.4K ﹤0.01% 13081
2021
Q4 		$83K Buy
+115,013
New +$93K ﹤0.01% 12914
2021
Q1 		– Sell
-21,965
Closed -$27K – 13945
2020
Q4 		$27K Buy
21,965
+8,116
+59% +$9.68K ﹤0.01% 10733
2020
Q3 		$17K Sell
13,849
-36,495
-72% -$44.4K ﹤0.01% 9893
2020
Q2 		$59K Buy
50,344
+22,594
+81% +$20.9K ﹤0.01% 9234
2020
Q1 		$23K Buy
+27,750
New +$29.4K ﹤0.01% 9268
2019
Q3 		– Sell
-18,304
Closed -$27K – 9981
2019
Q2 		$27K Sell
18,304
-18,928
-51% -$29.3K ﹤0.01% 8897
2019
Q1 		$57K Buy
37,232
+26,429
+245% +$40.3K ﹤0.01% 8773
2018
Q4 		$16K Sell
10,803
-17,096
-61% -$26.2K ﹤0.01% 8828
2018
Q3 		$51K Buy
+27,899
New +$54.1K ﹤0.01% 8803
2017
Q2 		– Sell
-12,482
Closed -$24K – 8275
2017
Q1 		$24K Buy
+12,482
New +$26.4K ﹤0.01% 7212
2015
Q4 		– Sell
-21,346
Closed -$45K – 9381
2015
Q3 		$45K Buy
+21,346
New +$41.6K ﹤0.01% 7658
2015
Q2 		– Sell
-10,795
Closed -$42K – 9211
2015
Q1 		$42K Buy
+10,795
New +$40K ﹤0.01% 7492

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Citadel Advisors's MBII Position: Q2 2022 in Review

Citadel Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 29,791 shares — an estimated $32K sold.

Citadel Advisors first reported a position in MBII in Q1 2015 and held it in 13 quarters. The position peaked at $83K in Q4 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Citadel Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 29,791 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $32K.
  • Citadel Advisors first reported a position in Marrone Bio Innovations, Inc. in Q1 2015 and held it in 13 quarters.
  • Citadel Advisors's Marrone Bio Innovations, Inc. position peaked at $83K in Q4 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.